ViroGates A/S (CPH:VIRO)
Denmark · Delayed Price · Currency is DKK 9.92
-0.13 (-1.29%)
Sep 17, 2025, 4:21 PM CET
ViroGates Market Cap
ViroGates has a market cap or net worth of 76.73 million as of September 17, 2025. Its market cap has increased by 86.01% in one year.
Market Cap
76.73M
Enterprise Value
69.89M
Revenue
9.40M
Ranking
n/a
PE Ratio
n/a
Stock Price
9.92
Market Cap Chart
Since June 26, 2018, ViroGates's market cap has decreased from 259.22M to 76.73M, a decrease of -70.40%. That is a compound annual growth rate of -15.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2025 | 77.73M | -5.19% |
| Dec 30, 2024 | 81.99M | 111.23% |
| Dec 29, 2023 | 38.81M | -71.09% |
| Dec 30, 2022 | 134.25M | -70.57% |
| Dec 30, 2021 | 456.12M | 79.21% |
| Dec 30, 2020 | 254.51M | 144.75% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Jun 26, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1,595.64B |
| Coloplast | 134.33B |
| Genmab | 109.23B |
| Demant | 50.91B |
| ALK-Abelló | 45.79B |
| H. Lundbeck | 40.58B |
| Zealand Pharma | 30.08B |
| Ambu A/S | 26.27B |